February 22, 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
February 8, 2018
GenomeDx Biosciences’ Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium
September 21, 2017
GenomeDx’s Decipher Cancer Classifier Tests and Genomic Database to be Featured in Multiple Presentations at ASTRO 2017
September 14, 2017
GenomeDx to Distribute Pathnostics’ Guidance UGx Test for Urinary Tract Infection and Guidance PRx Test for Prostatitis
July 24, 2017
GenomeDx Launches Hereditary Cancer Risk Genetic Testing by Color for Prostate Cancer Patients and Families
June 29, 2017
GenomeDx Announces New York State CLEP Approval of Decipher Prostate Cancer Tests
June 7, 2017
Multiple Studies Further Validate the Importance of Decipher Post-Op in the Treatment of Prostate Cancer
June 1, 2017
GenomeDx’s Decipher to be Featured in Multiple Presentations at ASCO 2017
May 12, 2017
GenomeDx and Color Collaborate to Further Advance Precision Medicine for Prostate Cancer Patients and their Families
May 11, 2017
